Amidst several mergers, acquisitions and funding rounds in the last year, Seattle Inno has named 22 startups to watch in 2022, including Mozart Therapeutics. The Seattle-based biotech raised $55M in October.
Katie Fanning, CEO of Mozart Therapeutics said she aims to improve treatment of autoimmune and inflammatory diseases the same way the famous composer changed music.